PERSPECTA

News from every angle

Back to headlines

RBC Capital Initiates Bristol Myers Coverage with $60 Target

RBC Capital initiates coverage on Bristol Myers (BMY) with a $60 target, noting the depth of its late-stage pipeline.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.